Project Grant R01HL177493
Award Date
8/1/25
Completion Date
5/31/29
Dollars Obligated
$498K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
West Virginia, USA
Similar Awards
The federal Project Grant award of $621,546.00 was granted on July 20, 2025 by the National Heart Lung and Blood Institute (NHLBI), under the CFDA 93.837 Cardiovascular Diseases Research program. The grant supports research focused on observing the catalytic subunit of cAMP-dependent protein kinase A (PKA-C) at the single molecule level, to understand its role in normal heart function and cardiac disease states. Key objectives include: Engineering a single-walled carbon nanotube field effect...
This $888,000 project grant from the National Heart, Lung and Blood Institute will fund research into the role of oxidative signaling through Na/K-ATPase in chronic kidney disease-induced anemia. The awardee, Marshall University Research Corporation, will investigate how accelerated red blood cell eryptosis, or premature cell death, contributes to anemia development and progression in chronic kidney disease. Two specific aims will be pursued: 1) defining the role of adipocytes and global...
This federal Project Grant award, totaling $2,158,428 and funded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports research aimed at investigating the role of the glycolytic enzyme pyruvate kinase M2 (PKM2) in mediating hypertension and vascular remodeling. The award supports three specific aims: 1) Studying the involvement of PKM2 activation in vascular smooth muscle cells (VSMCs) in hypertension and vascular...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $420,600 Project Grant under CFDA 93.837 - Cardiovascular Diseases Research to the University of Colorado-Denver. The grant's objective is to design elastic hydrogel microparticles as a platform to measure key elements of platelet function, including adhesion, activation, aggregation, and contraction. This innovative "lab-on-a-particle" approach aims to improve the reliability and reproducibility of platelet function...
This Project Grant award of $122,268.00 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research on the role of mitochondrial acid-sensing ion channel 1 (ASIC1) in pulmonary hypertension. The research, conducted at the University of New Mexico Health Sciences Center, aims to define the mechanisms by which the sigma-1 receptor regulates the subcellular localization of ASIC1, which affects pulmonary arterial...
The federal Project Grant award R01HL177433, funded by the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research), supports a research project to investigate the structural dynamics and regulatory mechanisms of the Atrial Natriuretic Peptide Receptor (ANPR or GC-A) over a period of 4 years from December 2024 to November 2028. The $535,213 grant awarded to Weill Medical College of Cornell University aims to: 1) delineate the structural changes in GC-A upon...
This Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $121,003.00 to Case Western Reserve University to conduct research on the atomic-level structural-omics of platelet membrane proteins. The research aims to solve the structures of platelet membrane proteins in their native environment using advanced cryogenic electron microscopy (cryo-EM) techniques. This includes determining the in-situ...
This federal Project Grant award, with a total funding amount of $153,252, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award will support a 3-year research program focused on elucidating the molecular mechanisms and clinical significance of a specific macrophage population (SPP1+ macrophages) in peripheral arterial disease (PAD). The primary objectives are to determine if SPP1+ macrophages inhibit...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $385,000 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to the RU School of Osteopathic Medicine in Pennsylvania. The 5-year grant, which commenced on January 20, 2025, aims to investigate the role of mitochondrial magnesium in regulating mitochondrial calcium uptake and its impact on ischemic reperfusion injury and heart failure. The key objectives are to: 1) define the mechanism by which oxidative stress...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $764,817 to the University of North Carolina at Chapel Hill to conduct research on the mechanisms of coagulopathy and bleeding in acute promyelocytic leukemia (APL). The study aims to determine the individual contributions of the podoplanin-CLEC-2 pathway, the S100/Annexin A2/tissue plasminogen activator and the urokinase-type plasminogen...